Universal Cancer Conquest Llp - Company Profile

It is a healthcare limited liability partnership based in Pune, Maharashtra, India, established in 2015.
2015 Pune, Maharashtra, India Active
Last Updated:
Access Report
About Universal Cancer Conquest Llp

Universal Cancer Conquest Llp, a active limited liability partnership, was established on 18 June 2015 in Pune, Maharashtra, India. Engaging in oncology clinics & cancer treatment within the healthcare sector, it holds LLPIN: AAE-1995. Registered under ROC Roc Pune. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Ajay Walchand Balai (Designated Partner), Sachin Chopda Ashok (Designated Partner). Past directors included Ajay Walchand Balai, Anantbhushan Anil Ranade. Its latest date of accounts and solvency statement 31 March 2019. It is based at 635/1B, New Gajra Society, Bibwewadi, Pune, Maharashtra, 411037.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAE-1995

  • Incorporation Date

    18 June 2015

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 11 Year, 21 Days
  • Last Filing with ROC 31 Mar 2019
Company report

Universal Cancer Conquest Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Universal Cancer Conquest Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Universal Cancer Conquest Llp?
Current Designated Partners
Name Designation Appointment Date Status
Ajay Walchand Balai Designated Partner 31 Aug 2018 Current
Sachin Chopda Ashok Designated Partner 18 Jun 2015 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Partner 30 Aug 2018 Past
Pramod Abcsdd Designated Partner 31 Aug 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Universal Cancer Conquest Llp.

Enhance accessibility to Universal Cancer Conquest Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Universal Cancer Conquest Llp revenue growth over time
Universal Cancer Conquest Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Universal Cancer Conquest Llp?

Unlock access to Universal Cancer Conquest Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Universal Cancer Conquest Llp?

Unlock and access historical data on people associated with Universal Cancer Conquest Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Universal Cancer Conquest Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Universal Cancer Conquest Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Universal Cancer Conquest Llp
Recent Activity within the Organization
  • Annual General Meeting

    Universal Cancer Conquest Llp last Annual general meeting of members was held on 31 Mar 2019 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    Progress on Universal Cancer Conquest Llp has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Pune. was documented.

  • Director Appointment

    Ajay Walchand Balai was appointed as a Designated Partner was appointed as a Designated Partner on 31 Aug 2018 & has been associated with this company since 7 years 10 months . was recorded as a recent event.

  • Director Appointment

    The activity Sachin Chopda Ashok was appointed as a Designated Partner was appointed as a Designated Partner on 18 Jun 2015 & has been associated with this company since 11 years 21 days . was completed.

  • LLP Incorporation

    Progress on Universal Cancer Conquest Llp was registered on 18 Jun 2015 with Roc Pune & aged 11 years 21 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Universal Cancer Conquest Llp?

The LLPIN of Universal Cancer Conquest Llp is AAE-1995.

Where is Universal Cancer Conquest Llp headquartered?

Universal Cancer Conquest Llp is headquartered at 635/1B, New Gajra Society, Bibwewadi, Pune, Maharashtra, 411037.

When was Universal Cancer Conquest Llp incorporated?

Universal Cancer Conquest Llp was incorporated on 18 June 2015.

Who are the current directors of Universal Cancer Conquest Llp?

The current directors of Universal Cancer Conquest Llp are

What is the primary industry of Universal Cancer Conquest Llp?

The primary industry of Universal Cancer Conquest Llp is Healthcare.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available